Effects of levamisole in Sézary syndrome. Apparent acceleration of disease.
Dermatologica, 1979;159(6):461-5.
PMID: 159840
Abstract
2 patients with Sézary syndrome were treated with levamisole. Both patients had clinical and hematological evidence of acceleration of their disease and ultimately died, although 1 patient had improvement in skin test reactivity. We suggest that levamisole be used with caution, if at all, in patients with T-lymphocyte malignancies.
MeSH terms
Adult; Dermatitis, Exfoliative; Female; Humans; Levamisole; Middle Aged; Sezary Syndrome; Skin; Skin Tests; T-Lymphocytes
More resources
EndNote: Download